আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
mercilon tafla 150 míkróg/20 míkróg
n.v. organon* - desogestrelum inn; ethinylestradiolum inn - tafla - 150 míkróg/20 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
desirett (desogestrel) filmuhúðuð tafla 75 míkróg
exeltis healthcare s.l. - desogestrelum inn - filmuhúðuð tafla - 75 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
gestrina filmuhúðuð tafla 75 míkróg
teva b.v.* - desogestrelum inn - filmuhúðuð tafla - 75 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
cerazette filmuhúðuð tafla 75 míkróg
n.v. organon* - desogestrelum inn - filmuhúðuð tafla - 75 míkróg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
nuvaring leggangainnlegg 0,120 mg/0,015 mg/24 klst.
n.v. organon* - etonogestrelum inn; ethinylestradiolum inn - leggangainnlegg - 0,120 mg/0,015 mg/24 klst.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
ornibel leggangainnlegg 0,120mg / 0,015 mg/24 klst.
exeltis healthcare s.l. - etonogestrelum inn; ethinylestradiolum inn - leggangainnlegg - 0,120mg / 0,015 mg/24 klst.
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
nexplanon (implanon nxt 68 mg vefjalyf) vefjalyf 68 mg
n.v. organon* - etonogestrelum inn - vefjalyf - 68 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
cleodette filmuhúðuð tafla 3 mg/0,02 mg
teva b.v.* - drospirenonum inn; ethinylestradiolum inn - filmuhúðuð tafla - 3 mg/0,02 mg
আইসলণ্ড -
আইসল্যান্ডীয় -
LYFJASTOFNUN (Icelandic Medicines Agency)
cyproteroneacetat/etinylestradiol alvogen (cypretyl) húðuð tafla 2/0,035 mg
alvogen ehf. - ethinylestradiolum inn; cyproteronum acetat - húðuð tafla - 2/0,035 mg
ইউরোপীয় ইউনিয়ন -
আইসল্যান্ডীয় -
EMA (European Medicines Agency)
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - ofsabjúgur, arfgengur - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.